Luc-André Granier

International Association for the Study of Pain operates as a professional forum for science, practice, and education in the field of pain. It brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain. The company was founded in 1973 and is headquartered in Washington, DC.

Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France.

Located in Alsace, in the heart of Europe, Forenap Pharma is an International Contract Research Organization (CRO) combined with a 'Site Management Organization' (SMO) specialized in early Drug Development and Research in Neuroscience. Founded in 1986, FORENAP has succeeded in developing in the past 20 years a unique expertise in Central Nervous System. It currently employs 180 people. FORENAP Group is made of two main lines of skills: FORENAP Pharma: preclinical and clinical studies management as well as related business activities; FORENAP FRP: dedicated to scientific research. FORENAP proposes optimized development plans and ensures the management of preclinical, Phase I (in all therapeutic areas) and Phase II (for Central Nervous System and Cardiovascular compounds) studies. With its own 72-bed centre. FORENAP offers a 'full services package' (including 'consulting' services) to bring customers projects to success, from Drug Discovery to Marketing authorization.

American Society of Nephrology operates as a professional society devoted to the study of kidney disease. The company is headquartered in Washington, DC.